Here is our chance to tell them what we are using!!!

[Guest guest]

Last year, HealthTalk asked members what programming they wanted to see. You told us overwhelmingly that you want the latest information, targeted to the circumstances of your condition (see detailed results below). Now we want to learn more about our members so that we can better tailor programming to your needs. By taking our survey, you will have a direct influence on the programs we deliver.

Take the survey

If you do not accept HTML messages, copy the link below and paste it into your browser window: http://www.healthtalk.com/customcf/cct.cfm?iCCT=3213 & iCS=8821973 As with all of HealthTalk's research projects, the privacy of each participant will be protected. Only the combined results of the research will be reported; no individual information will be released. Wishing you and your family the best of health, The HealthTalk Market Research Team

Member Survey Results Overall, HealthTalk members overwhelmingly find expert advice and the latest news the most helpful content on our site. Further, 30% of members prefer this information delivered via e-mail newsletters and webcasts. When asked what programming they would like to see, members chose "latest information on drug therapy" most often (see chart below).

About HealthTalk | Editorial & Privacy Policy | Contact Us | Unsubscribe

You received this message because you signed up for one or more newsletters on www.healthtalk.com. This is part of HealthTalk's regular mailings to subscribers, which includes newsletters, event announcements, reminders and invitations for feedback and surveys. Please do not reply to this message. It was sent from an unmonitored e-mail address and we are unable to respond to any replies.

HealthTalk is located at 100 4th Avenue North, Suite 460, Seattle, WA 98109.

[Guest guest]

We are sorry but this survey is no longer available is all I get!

Reg.

-------Original Message-------

From: low dose naltrexone

Date: 03/26/04 11:59:13

low dose naltrexone ; spotlight_ldn

Subject: [low dose naltrexone] Here is our chance to tell them what we are using!!!

Last year, HealthTalk asked members what programming they wanted to see. You told us overwhelmingly that you want the latest information, targeted to the circumstances of your condition (see detailed results below). Now we want to learn more about our members so that we can better tailor programming to your needs. By taking our survey, you will have a direct influence on the programs we deliver.

Take the survey

If you do not accept HTML messages, copy the link below and paste it into your browser window: http://www.healthtalk.com/customcf/cct.cfm?iCCT=3213 & iCS=8821973 As with all of HealthTalk's research projects, the privacy of each participant will be protected. Only the combined results of the research will be reported; no individual information will be released. Wishing you and your family the best of health, The HealthTalk Market Research Team

Member Survey Results Overall, HealthTalk members overwhelmingly find expert advice and the latest news the most helpful content on our site. Further, 30% of members prefer this information delivered via e-mail newsletters and webcasts. When asked what programming they would like to see, members chose "latest information on drug therapy" most often (see chart below).

About HealthTalk | Editorial & Privacy Policy | Contact Us | Unsubscribe

You received this message because you signed up for one or more newsletters on www.healthtalk.com. This is part of HealthTalk's regular mailings to subscribers, which includes newsletters, event announcements, reminders and invitations for feedback and surveys. Please do not reply to this message. It was sent from an unmonitored e-mail address and we are unable to respond to any replies.

HealthTalk is located at 100 4th Avenue North, Suite 460, Seattle, WA 98109.

____________________________________________________ IncrediMail - Email has finally evolved - Click Here